Most positive HIV western blot tests do not diagnose new cases in New York City: Implications for HIV testing programs

David B. Hanna, Benjamin W. Tsoi, Elizabeth M. Begier

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

OBJECTIVE:: To evaluate HIV testing efforts based on surveillance data. METHODS:: We determined the contribution of new diagnoses to all positive confidential HIV-1 Western blotting conducted in New York City between 2004 and 2006 based on clinical history recorded in the HIV Surveillance Registry, by testing site type. RESULTS:: Of 31,504 positive Western blots reported and linked to Registry cases, 36.8% were new diagnoses and 63.2% were repeat positive tests. City health department clinics and private physicians' offices reported greater proportions of new diagnoses than other testing sites (64.4% and 58.3% vs. 31.1%). The percentage of positive tests at health department clinics that were new diagnoses increased from 59.8% in 2004 to 69.0% in 2006 (P = 0.001), coinciding with efforts to expand HIV testing. Repeat positive testers were significantly older, more likely to have an injection drug use history or AIDS, and less likely to be foreign-born. CONCLUSIONS:: Repeat testing of known HIV-infected persons is common and an inefficient use of HIV prevention resources when the purpose of testing is to diagnose previously unidentified infections. Initiatives to increase HIV testing should be evaluated routinely using surveillance data to determine the proportion of infected persons identified who are newly diagnosed.

Original languageEnglish (US)
Pages (from-to)609-614
Number of pages6
JournalJournal of Acquired Immune Deficiency Syndromes
Volume51
Issue number5
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Western Blotting
HIV
Registries
Physicians' Offices
Health
HIV-1
Acquired Immunodeficiency Syndrome
Injections
Infection
Pharmaceutical Preparations

Keywords

  • Case finding
  • Evaluation studies
  • HIV diagnostic tests
  • Surveillance
  • Western blotting

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Most positive HIV western blot tests do not diagnose new cases in New York City : Implications for HIV testing programs. / Hanna, David B.; Tsoi, Benjamin W.; Begier, Elizabeth M.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 51, No. 5, 08.2009, p. 609-614.

Research output: Contribution to journalArticle

@article{0aa935240cc64d0998528b19a83b931e,
title = "Most positive HIV western blot tests do not diagnose new cases in New York City: Implications for HIV testing programs",
abstract = "OBJECTIVE:: To evaluate HIV testing efforts based on surveillance data. METHODS:: We determined the contribution of new diagnoses to all positive confidential HIV-1 Western blotting conducted in New York City between 2004 and 2006 based on clinical history recorded in the HIV Surveillance Registry, by testing site type. RESULTS:: Of 31,504 positive Western blots reported and linked to Registry cases, 36.8{\%} were new diagnoses and 63.2{\%} were repeat positive tests. City health department clinics and private physicians' offices reported greater proportions of new diagnoses than other testing sites (64.4{\%} and 58.3{\%} vs. 31.1{\%}). The percentage of positive tests at health department clinics that were new diagnoses increased from 59.8{\%} in 2004 to 69.0{\%} in 2006 (P = 0.001), coinciding with efforts to expand HIV testing. Repeat positive testers were significantly older, more likely to have an injection drug use history or AIDS, and less likely to be foreign-born. CONCLUSIONS:: Repeat testing of known HIV-infected persons is common and an inefficient use of HIV prevention resources when the purpose of testing is to diagnose previously unidentified infections. Initiatives to increase HIV testing should be evaluated routinely using surveillance data to determine the proportion of infected persons identified who are newly diagnosed.",
keywords = "Case finding, Evaluation studies, HIV diagnostic tests, Surveillance, Western blotting",
author = "Hanna, {David B.} and Tsoi, {Benjamin W.} and Begier, {Elizabeth M.}",
year = "2009",
month = "8",
doi = "10.1097/QAI.0b013e3181a4488f",
language = "English (US)",
volume = "51",
pages = "609--614",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Most positive HIV western blot tests do not diagnose new cases in New York City

T2 - Implications for HIV testing programs

AU - Hanna, David B.

AU - Tsoi, Benjamin W.

AU - Begier, Elizabeth M.

PY - 2009/8

Y1 - 2009/8

N2 - OBJECTIVE:: To evaluate HIV testing efforts based on surveillance data. METHODS:: We determined the contribution of new diagnoses to all positive confidential HIV-1 Western blotting conducted in New York City between 2004 and 2006 based on clinical history recorded in the HIV Surveillance Registry, by testing site type. RESULTS:: Of 31,504 positive Western blots reported and linked to Registry cases, 36.8% were new diagnoses and 63.2% were repeat positive tests. City health department clinics and private physicians' offices reported greater proportions of new diagnoses than other testing sites (64.4% and 58.3% vs. 31.1%). The percentage of positive tests at health department clinics that were new diagnoses increased from 59.8% in 2004 to 69.0% in 2006 (P = 0.001), coinciding with efforts to expand HIV testing. Repeat positive testers were significantly older, more likely to have an injection drug use history or AIDS, and less likely to be foreign-born. CONCLUSIONS:: Repeat testing of known HIV-infected persons is common and an inefficient use of HIV prevention resources when the purpose of testing is to diagnose previously unidentified infections. Initiatives to increase HIV testing should be evaluated routinely using surveillance data to determine the proportion of infected persons identified who are newly diagnosed.

AB - OBJECTIVE:: To evaluate HIV testing efforts based on surveillance data. METHODS:: We determined the contribution of new diagnoses to all positive confidential HIV-1 Western blotting conducted in New York City between 2004 and 2006 based on clinical history recorded in the HIV Surveillance Registry, by testing site type. RESULTS:: Of 31,504 positive Western blots reported and linked to Registry cases, 36.8% were new diagnoses and 63.2% were repeat positive tests. City health department clinics and private physicians' offices reported greater proportions of new diagnoses than other testing sites (64.4% and 58.3% vs. 31.1%). The percentage of positive tests at health department clinics that were new diagnoses increased from 59.8% in 2004 to 69.0% in 2006 (P = 0.001), coinciding with efforts to expand HIV testing. Repeat positive testers were significantly older, more likely to have an injection drug use history or AIDS, and less likely to be foreign-born. CONCLUSIONS:: Repeat testing of known HIV-infected persons is common and an inefficient use of HIV prevention resources when the purpose of testing is to diagnose previously unidentified infections. Initiatives to increase HIV testing should be evaluated routinely using surveillance data to determine the proportion of infected persons identified who are newly diagnosed.

KW - Case finding

KW - Evaluation studies

KW - HIV diagnostic tests

KW - Surveillance

KW - Western blotting

UR - http://www.scopus.com/inward/record.url?scp=68449086885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68449086885&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3181a4488f

DO - 10.1097/QAI.0b013e3181a4488f

M3 - Article

C2 - 19430305

AN - SCOPUS:68449086885

VL - 51

SP - 609

EP - 614

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -